Race Against Time: Call for a National Response to the Dementia Crisis

The Conference Board of Canada, 2 pages, March 1, 2022
Summary for Executives by
(You must be signed in and entitled to rate this report)


Alzheimer’s disease is a growing concern in Canada. Scientific progress is shedding more light on its pathology and opening doors to new treatments. Are Canada’s healthcare systems able to support access?

Document Highlights

Dementia currently affects over half a million Canadians. By 2030, this will nearly double to 912,000. Alzheimer’s disease (AD), the most common cause of dementia, is the eighth leading cause of death in Canada, killing over 6,000 Canadians every year. In 2021, AD and other dementias will cost Canada an estimated $11.3 billion in both direct and indirect expenses. This is projected to rise to $16.6 billion by 2030.

Disease-modifying therapies for AD in Canada are on the horizon. They have the potential to bring lasting change by either slowing down or stopping its progression. Race Against Time: Call for a National Response to the Dementia Crisis shines light on the significant gaps that exist in Canada’s dementia care capacity and offers recommendations to help Canada prepare its healthcare systems.

COVID-19: Get all the insights

Price: $0

No charge, funded by The Conference Board of Canada and/or the research sponsor

Browse by...
Need Help?